Cargando…
Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions
Microbiological data are used as indicators of infection, for diagnosis, and the identification of antimicrobial resistance in trials of antimicrobial stewardship interventions. However, several problems have been identified in a recently conducted systematic review (e.g., inconsistency in reporting...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215498/ https://www.ncbi.nlm.nih.gov/pubmed/37237788 http://dx.doi.org/10.3390/antibiotics12050885 |
_version_ | 1785048077446414336 |
---|---|
author | Lau, Tin Man Mandy Daniel, Rhian Hood, Kerenza Wootton, Mandy Hughes, Kathryn Stuart, Beth Hayward, Gail Szakmany, Tamas Gillespie, David |
author_facet | Lau, Tin Man Mandy Daniel, Rhian Hood, Kerenza Wootton, Mandy Hughes, Kathryn Stuart, Beth Hayward, Gail Szakmany, Tamas Gillespie, David |
author_sort | Lau, Tin Man Mandy |
collection | PubMed |
description | Microbiological data are used as indicators of infection, for diagnosis, and the identification of antimicrobial resistance in trials of antimicrobial stewardship interventions. However, several problems have been identified in a recently conducted systematic review (e.g., inconsistency in reporting and oversimplified outcomes), which motivates the need to understand and improve the use of these data including analysis and reporting. We engaged key stakeholders including statisticians, clinicians from both primary and secondary care, and microbiologists. Discussions included issues identified in the systematic review and questions about the value of using microbiological data in clinical trials, perspectives on current microbiological outcomes reported in trials, and alternative statistical approaches to analyse these data. Various factors (such as unclear sample collection process, dichotomising or categorising complex microbiological data, and unclear methods of handling missing data) were identified that contributed to the low quality of the microbiological outcomes and the analysis of these outcomes in trials. Whilst not all of these factors would be easy to overcome, there is room for improvement and a need to encourage researchers to understand the impact of misusing these data. This paper discusses the experience and challenges of using microbiological outcomes in clinical trials. |
format | Online Article Text |
id | pubmed-10215498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102154982023-05-27 Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions Lau, Tin Man Mandy Daniel, Rhian Hood, Kerenza Wootton, Mandy Hughes, Kathryn Stuart, Beth Hayward, Gail Szakmany, Tamas Gillespie, David Antibiotics (Basel) Brief Report Microbiological data are used as indicators of infection, for diagnosis, and the identification of antimicrobial resistance in trials of antimicrobial stewardship interventions. However, several problems have been identified in a recently conducted systematic review (e.g., inconsistency in reporting and oversimplified outcomes), which motivates the need to understand and improve the use of these data including analysis and reporting. We engaged key stakeholders including statisticians, clinicians from both primary and secondary care, and microbiologists. Discussions included issues identified in the systematic review and questions about the value of using microbiological data in clinical trials, perspectives on current microbiological outcomes reported in trials, and alternative statistical approaches to analyse these data. Various factors (such as unclear sample collection process, dichotomising or categorising complex microbiological data, and unclear methods of handling missing data) were identified that contributed to the low quality of the microbiological outcomes and the analysis of these outcomes in trials. Whilst not all of these factors would be easy to overcome, there is room for improvement and a need to encourage researchers to understand the impact of misusing these data. This paper discusses the experience and challenges of using microbiological outcomes in clinical trials. MDPI 2023-05-10 /pmc/articles/PMC10215498/ /pubmed/37237788 http://dx.doi.org/10.3390/antibiotics12050885 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Lau, Tin Man Mandy Daniel, Rhian Hood, Kerenza Wootton, Mandy Hughes, Kathryn Stuart, Beth Hayward, Gail Szakmany, Tamas Gillespie, David Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions |
title | Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions |
title_full | Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions |
title_fullStr | Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions |
title_full_unstemmed | Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions |
title_short | Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions |
title_sort | perspectives of statistician, microbiologist, and clinician stakeholders on the use of microbiological outcomes in randomised trials of antimicrobial stewardship interventions |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215498/ https://www.ncbi.nlm.nih.gov/pubmed/37237788 http://dx.doi.org/10.3390/antibiotics12050885 |
work_keys_str_mv | AT lautinmanmandy perspectivesofstatisticianmicrobiologistandclinicianstakeholdersontheuseofmicrobiologicaloutcomesinrandomisedtrialsofantimicrobialstewardshipinterventions AT danielrhian perspectivesofstatisticianmicrobiologistandclinicianstakeholdersontheuseofmicrobiologicaloutcomesinrandomisedtrialsofantimicrobialstewardshipinterventions AT hoodkerenza perspectivesofstatisticianmicrobiologistandclinicianstakeholdersontheuseofmicrobiologicaloutcomesinrandomisedtrialsofantimicrobialstewardshipinterventions AT woottonmandy perspectivesofstatisticianmicrobiologistandclinicianstakeholdersontheuseofmicrobiologicaloutcomesinrandomisedtrialsofantimicrobialstewardshipinterventions AT hugheskathryn perspectivesofstatisticianmicrobiologistandclinicianstakeholdersontheuseofmicrobiologicaloutcomesinrandomisedtrialsofantimicrobialstewardshipinterventions AT stuartbeth perspectivesofstatisticianmicrobiologistandclinicianstakeholdersontheuseofmicrobiologicaloutcomesinrandomisedtrialsofantimicrobialstewardshipinterventions AT haywardgail perspectivesofstatisticianmicrobiologistandclinicianstakeholdersontheuseofmicrobiologicaloutcomesinrandomisedtrialsofantimicrobialstewardshipinterventions AT szakmanytamas perspectivesofstatisticianmicrobiologistandclinicianstakeholdersontheuseofmicrobiologicaloutcomesinrandomisedtrialsofantimicrobialstewardshipinterventions AT gillespiedavid perspectivesofstatisticianmicrobiologistandclinicianstakeholdersontheuseofmicrobiologicaloutcomesinrandomisedtrialsofantimicrobialstewardshipinterventions |